A large part of the WSJ article (and my post) focused on Dr. Robert Wadley, a pain physician in North Carolina who performs in-office urine drug toxicology testing and also owns a urine drug toxicology laboratory called AvuTox.
Dr. Wadley reached out with some comments about my post and the WSJ article earlier this morning, and in the interest of allowing both sides to present their side of the story, I would like to post his comments here.
Many thanks to Dr. Wadley for taking the time to help us understand his perspective.
What follows is Dr. Wadley’s complete and unedited comments.
To the writer of this blog,
It may be hard/impossible for you to comprehend facts. But to give you the benefit of the doubt, here is my response to the WSJ article. Note in it who made the recommendation that is being advanced by Palmetto, GBA that will save the Medicare trust fund $100’s of millions/year. It was not your precious Government nor a large reference lab, and it was not you.
I am R. Wadley, MD, the owner of BCIPS and AvuTox, and I would like to respond to this WSJ article.
To start with, the premise of the article is false. The author equated Medicare patients with the elderly. In a pain practice this notion is not true. This false premise implies that pain doctors are testing nursing home patients for illicit drugs purely to make money. The truth is Medicare also insures the disabled population and a subset of the disabled population are those suffering from chronic pain. In fact, my practice has a small fraction of what would be considered elderly. Rather, all of my Medicare patients have chronic pain for which we prescribe controlled substances. Our duty is not only to treat this pain but also to do our due diligence to ensure that the medications are being taken as we prescribe them. For this reason, yes I do and will, test all of my patients for prescribed and illicit medications.